Open AccessClinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma
Author(s) -
Sonia Mahajan,
Christopher A. Barker,
Bhuvanesh Singh,
Neeta PanditTaskar
Publication year - 2019
Publication title -
nuclear medicine communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.489
H-Index - 73
eISSN - 1473-5628
pISSN - 0143-3636
DOI - 10.1097/mnm.0000000000001029
Subject(s) - medicine , malignancy , histopathology , standardized uptake value , positron emission tomography , nuclear medicine , radiology , fluorodeoxyglucose , carcinoma , pathology
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin malignancy. Computed tomography (CT) and/or MRI are commonly used for staging, however, the role of fluorine-18-fluorodeoxyglucose (F-FDG)-PET is not clearly established. In this study, we evaluated F-FDG-PET/CT imaging for initial staging of cSCC.